Abstract
Anti-coagulation treatments are required for medical conditions that become more and more frequent with the ageing of the population in developed countries (atrial fibrillation, deep-venous thrombosis, heart prosthetic valves, etc.). These treatments generally use coumarin derivative (vitamin-K antagonist), whose activity needs to be monitored in order to keep the patient in an appropriate therapeutic range. This measurement can be done in laboratories but can also be performed by the patient himself using portable devices. This paper presents the different technological ways to selfmonitor vitamin-K antagonist treatment by measuring coagulation time. It will focus on portable devices, well suited to be used at home and on device to be manipulated by the patient, thus not requiring an extensive training nor sample treatment.
Keywords: Anti-coagulant, vitamin-K antagonist, coagulation, coagulation time measurement, coumarin, diagnostic, hand-held devices, international normalized ratio, point-of-care, portable devices, prothrombin time, Quick test, self-monitoring, thromboses prevention.
Current Biotechnology
Title:Portable Technologies for Self-Monitoring of Coagulation Time: A Review
Volume: 1 Issue: 2
Author(s): Lynda Metref and Philippe Renaud
Affiliation:
Keywords: Anti-coagulant, vitamin-K antagonist, coagulation, coagulation time measurement, coumarin, diagnostic, hand-held devices, international normalized ratio, point-of-care, portable devices, prothrombin time, Quick test, self-monitoring, thromboses prevention.
Abstract: Anti-coagulation treatments are required for medical conditions that become more and more frequent with the ageing of the population in developed countries (atrial fibrillation, deep-venous thrombosis, heart prosthetic valves, etc.). These treatments generally use coumarin derivative (vitamin-K antagonist), whose activity needs to be monitored in order to keep the patient in an appropriate therapeutic range. This measurement can be done in laboratories but can also be performed by the patient himself using portable devices. This paper presents the different technological ways to selfmonitor vitamin-K antagonist treatment by measuring coagulation time. It will focus on portable devices, well suited to be used at home and on device to be manipulated by the patient, thus not requiring an extensive training nor sample treatment.
Export Options
About this article
Cite this article as:
Metref Lynda and Renaud Philippe, Portable Technologies for Self-Monitoring of Coagulation Time: A Review, Current Biotechnology 2012; 1 (2) . https://dx.doi.org/10.2174/2211550111201020155
DOI https://dx.doi.org/10.2174/2211550111201020155 |
Print ISSN 2211-5501 |
Publisher Name Bentham Science Publisher |
Online ISSN 2211-551X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
The Successful Treatment of Pulmonary Embolism as a Complication after Uterine Fibroid Embolization (Case Report)
Current Women`s Health Reviews Proteoglycan Involvement in Inflammatory Diseases. New Developments in GAG-Based Therapies
Medicinal Chemistry Reviews - Online (Discontinued) Hypercoagulability and Nephrotic Syndrome
Current Vascular Pharmacology Metabolic Syndrome and Myocardial Infarction in Women
Current Pharmaceutical Design Direct Thrombin Inhibitors for the Prevention of Venous Thromboembolism after Major Orthopaedic Surgery
Current Pharmaceutical Design The Appearance of Middle Meningeal Artery Fistulae After Willis Covered Stent for Traumatic Carotid-cavernous Fistulae: Two Case Reports
Current Medical Imaging Mechanical Thrombectomy in Acute Ischaemic Stroke: A Review of the Literature, Clinical Effectiveness and Future Use
CNS & Neurological Disorders - Drug Targets Clinical Presentations and Diagnosis of Brucellosis
Recent Patents on Anti-Infective Drug Discovery The Role of Hypoxia and Platelets in Air Travel-Related Venous Thromboembolism
Current Pharmaceutical Design Balancing the Risks of Thrombosis and Bleeding Following Transcatheter Aortic Valve Implantation: Current State-of-Evidence
Current Pharmaceutical Design Bioabsorbable Coronary Stents - Are These the Next Big Thing in Coronary Angioplasty?
Recent Patents on Cardiovascular Drug Discovery Lone Atrial Fibrillation- A Diagnosis of Exclusion
Current Pharmaceutical Design Heparin - a Key Drug in the Treatment of the Circulatory Degenerative Diseases: Controlling its Action with Polymers
Current Pharmaceutical Design Takotsubo Cardiomyopathy: What we have Learned in the Last 25 Years? (A Comparative Literature Review)
Current Cardiology Reviews Anticoagulant Therapy in Pregnant Patients with Metabolic Syndrome: A Review
Current Pharmaceutical Biotechnology Recent Advancement in the Treatment of Cardiovascular Diseases: Conventional Therapy to Nanotechnology
Current Pharmaceutical Design Phosphodiesterase Inhibition as a Therapeutic Target for Brain Ischemia
CNS & Neurological Disorders - Drug Targets Lenalidomide for Treatment of Myelodysplastic Syndromes
Current Pharmaceutical Design Role of Coronary Microvascular Endothelial Dysfunction in the Development of Heart Failure
Current Cardiology Reviews Analgesic Considerations for Liver Transplantation Patients
Current Clinical Pharmacology